ACB $6.950 (-6.21%)

ACNNF $0.277 (10.6%)

AERO $1.290 (-5.15%)

AGEEF $0.418 (-2.79%)

ALEAF $0.890 (-2.85%)

AMMJ $0.271 (2.32%)

APHA $6.450 (-1.68%)

ARNA $61.950 (1.03%)

ATT:CNX $0.080 (0%)

ATTBF $0.028 (-5.98%)

AUSA:CNX $0.970 (-2.02%)

AUSAF $0.746 (-1.83%)

AVXL $2.820 (-7.84%)

BAMM:CNX $1.090 (3.81%)

BBM:CNX $0.285 (-5%)

BBRRF $0.224 (-3.86%)

BE:CNX $0.080 (6.67%)

BIO:CNX $0.340 (-11.69%)

BLEVF $0.054 (-3.98%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.910 (-10.78%)

BLOZF $0.700 (-9.68%)

BUDZ $0.577 (4.91%)

BXNG $0.530 (8.14%)

CADMF $1.180 (-1.05%)

CALI:CNX $0.130 (-10.34%)

CANN $0.750 (-3.84%)

CARA $25.340 (-5.83%)

CBII:CNX $0.195 (2.63%)

CBIIF $0.156 (4.51%)

CBWTF $0.547 (-1.08%)

CGC $35.800 (-2.16%)

CGRW $0.305 (-1.64%)

CHOO:CNX $0.400 (-2.44%)

CHOOF $0.308 (-3.75%)

CNAB $0.761 (19.47%)

CNBX $0.310 (-6.06%)

CNGGF $1.409 (0%)

CODI $19.240 (-1.43%)

CPMD $1.520 (0%)

CRBP $6.200 (-2.05%)

CRON $14.960 (-0.2%)

CROP:CNX $0.175 (6.06%)

CRTPF $3.908 (-0.91%)

CRXPF $0.127 (-2.23%)

CSI:CNX $1.530 (-2.55%)

CTST $2.930 (2.45%)

CURR $5.150 (-0.96%)

CVSI $4.200 (0%)

DIGP $0.110 (4.67%)

DXBRF $0.430 (-3.63%)

EAPH $0.005 (4.44%)

EAT:CNX $0.175 (-5.41%)

EEVVF $0.278 (4.2%)

EMHTF $1.691 (-4.46%)

EPWCF $0.099 (6.45%)

EVIO $0.465 (-3.63%)

FFRMF $0.070 (1.88%)

FFT:CNX $0.090 (0%)

FNNZF $0.095 (-16.18%)

FSDDF $0.106 (-0.75%)

GGTTF $0.344 (-3.45%)

GLDFF $0.041 (-7.11%)

GLH:CNX $0.055 (0%)

GLNNF $0.070 (-2.43%)

GNBT $3.140 (5.72%)

GRIN:CNX $0.220 (41.94%)

GRWG $3.950 (6.47%)

GSTR:CNX $0.195 (11.43%)

GTBIF $9.200 (-2.2%)

GTII:CNX $12.000 (-2.12%)

GWPH $166.010 (1.85%)

HEXO $5.000 (-1.96%)

HHPHF $0.234 (0%)

HLSPY $0.650 (0%)

HMLSF $12.989 (-1.6%)

HMPPF $0.580 (-6.06%)

HRVOF $0.485 (-0.61%)

HSTRF $0.244 (0%)

HUGE:CNX $0.135 (0%)

IAN:CNX $3.640 (-6.91%)

IGC $1.310 (-7.75%)

IGXT $0.500 (2.04%)

IIPR $123.600 (-1.66%)

IMLFF $0.258 (2.51%)

INQD $0.012 (-13.89%)

IONC:CNX $0.220 (-10.2%)

ISOL:CNX $0.590 (1.72%)

ISOLF $0.453 (3.03%)

ITHUF $2.800 (-5.5%)

IVITF $0.293 (1.14%)

JWCAF $0.484 (-0.82%)

KALTF $0.029 (-2%)

KBEV:CNX $0.265 (-14.52%)

KBEVF $0.205 (-13.17%)

KHRNF $1.720 (-2.61%)

KSHB $4.930 (0%)

LDS:CNX $0.250 (-3.85%)

LDSYF $0.197 (-9.22%)

LHS:CNX $0.570 (-1.72%)

LHSIF $0.432 (-0.44%)

LOVE:CNX $0.160 (0%)

LXLLF $1.251 (127.45%)

LXRP $0.790 (0%)

LXX:CNX $1.060 (2.91%)

MCIG $0.062 (1.59%)

MDCL $3.110 (-3.72%)

MEDIF $3.750 (4.54%)

MGWFF $0.068 (-9.81%)

MICWF $0.160 (2.56%)

MJ:CNX $0.315 (0%)

MJNA $0.050 (0%)

MNTR $0.315 (5%)

MRRCF $0.293 (-16.4%)

MWM:CNX $0.205 (2.5%)

MYM:CNX $0.400 (-3.61%)

MYMMF $0.310 (-2.3%)

NCNNF $0.616 (-2.16%)

NDVAF $0.312 (0%)

NGW:CNX $0.300 (-3.23%)

NRXCF $0.056 (0%)

NSPDF $0.110 (-1.04%)

NTEC $3.390 (6.6%)

NVTQF $0.018 (0%)

NWKRF $0.424 (0%)

NXGWF $0.238 (-2.23%)

NXTTF $0.405 (-4.44%)

OH:CNX $6.950 (-5.18%)

ORHOF $5.380 (-4.44%)

OWCP $0.013 (9.65%)

PHGI:CNX $0.290 (-9.38%)

PHGRF $0.220 (-6.22%)

PHVAF $0.278 (-2.42%)

PILL:CNX $0.690 (4.55%)

PKG:CNX $0.230 (-2.13%)

PLPRF $2.689 (-1.29%)

PLUS:CNX $3.500 (-1.41%)

PMCB $0.040 (3.08%)

PNPL $0.260 (0%)

POTN $0.061 (4.99%)

PRCNF $0.071 (-11.06%)

PTNYF $0.179 (0.68%)

PUFXF $0.255 (-8.6%)

QCA:CNX $0.155 (-3.13%)

RDDTF $0.590 (-3.28%)

RLLVF $0.054 (-3.65%)

RMHB $0.099 (-10.01%)

RQB:CNX $0.460 (0%)

RQHTF $0.189 (-1%)

RVVQF $0.357 (0.25%)

SLNG:CNX $1.500 (-3.85%)

SMG $103.170 (0.25%)

SNN:CNX $2.400 (-0.41%)

SNNVF $1.800 (-1.71%)

SOL:CNX $1.660 (-6.74%)

SOLCF $1.290 (-5.15%)

SPLIF $0.133 (0.84%)

SPRWF $1.140 (-2.52%)

SRNA $0.025 (3.56%)

STEM:CNX $1.500 (4.17%)

STMH $1.250 (12.61%)

SUN:CNX $0.560 (1.82%)

TBPMF $0.202 (2.54%)

TCAN:CNX $1.730 (33.08%)

TCNAF $1.260 (12.91%)

TER:CNX $6.550 (1.71%)

TGEN $3.410 (0.29%)

TGIF:CNX $0.420 (-2.33%)

TGIFF $0.322 (1.07%)

THC:CNX $0.200 (0%)

THCBF $0.147 (-0.74%)

TLRY $43.410 (-1.9%)

TOKI:CNX $0.090 (5.88%)

TRLFF $0.255 (4.13%)

TRPX $2.360 (-4.45%)

TRSSF $4.948 (0.37%)

TRTC $0.398 (-5.36%)

TURV $0.680 (-2.86%)

VAPN:CNX $1.800 (0%)

VBIO $0.260 (4%)

VIDA:CNX $0.370 (1.37%)

VIN:CNX $0.520 (0%)

VPRB $0.045 (-8.74%)

VRNDF $0.762 (-3.1%)

VRT:CNX $0.255 (-3.77%)

VRTHF $0.199 (-1.49%)

VVCIF $0.384 (-3.06%)

WAYL:CNX $0.740 (0%)

WDDMF $1.205 (-3.62%)

WLDFF $0.423 (3.15%)

XXII $1.910 (-1.04%)

ZDPY $0.290 (-3.33%)

ZYNE $11.870 (1.63%)

Technical420 Site Search

Returned 33 result(s).

5 Canadian Licensed Producers You CAN Trust

Canadian Licensed Producers (LPs) have once again become a focal point of the cannabis industry after recently coming under considerable pressure, a trend that we have been closely monitoring. During the last month, Canadian LPs have been trending lower and we believe that this weakness is the result of two…

CannTrust Voluntary Hold On Product Sales and Formation of Independent Special Committee of the Board of Directors

CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) has announced it has implemented a voluntary hold on sale and shipment of all cannabis products as a precaution while Health Canada visits and reviews its Vaughan, Ontario manufacturing facility. CannTrust placed a hold on medical sales through their…

CannTrust Provides Update on Outdoor Cultivation and First Shipment to Australia

Today, CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) announced an update on its outdoor cultivation operation in British Columbia and its first shipment of capsule and dry flower products to Australia. Outdoor Cultivation Update After closing the purchase of its first 81 acres of land in…

5 Canadian LP Updates Investors Need To Know

The last week has been a relatively busy period for Canadian Licensed Producers (LPs) and this a trend to be watching. Last year, Canada legalized recreational cannabis, and this was a major catalyst for the companies that are levered to this market. Later this year, we expect to see a…

CannTrust Launches Three New Medical Cannabis Product Formulations

CannTrust Holdings Inc. (TSX: TRST, NYSE: CTST) is pleased to announce that it has launched three new cannabis extract formulations to meet the growing demand for oil-based products. The new formulations are designed to fill previously unmet needs within the Canadian medical market, identified through market research and the Company's…

CannTrust Receives Health Canada Approval for Phase 2 Expansion

CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST, NYSE:CTST) is pleased to announce that its cultivation and processing permit under Health Canada Cannabis Regulations was amended to include the final 20% of its Phase 2 expansion. The entire 450,000 sq. ft. of its perpetual harvest greenhouse in Pelham, Ontario, is…

CannTrust to Proceed Immediately with Phase III Construction in Town of Pelham

CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading, most trusted licensed producers of cannabis and the 2018 Canadian Cannabis Awards "Top Licensed Producer of the Year", is pleased to announce it has obtained the necessary permitting from the Town of Pelham to proceed with its…

CannTrust Applies to List on NYSE

CannTrust Holdings Inc. (TSX: TRST), one of Canada's leading, most trusted licensed producers of cannabis and the 2018 Canadian Cannabis Awards "Top Licensed Producer of the Year", announces that it has applied to list its common shares on the New York Stock Exchange.Listing of the Company's common shares on the…

CannTrust Provides Business Update

CannTrust Holdings Inc. (TSX: TRST), one of Canada's leading, most trusted licensed producers of cannabis and the 2018 Canadian Cannabis Awards "Top Licensed Producer of the Year", is providing an update to highlight recent developments regarding the Company's expansion plans.Phase II ExpansionThe fully-permitted Phase II expansion remains on course to…

CannTrust Ships CBD Oil Capsules to Gold Coast University for Clinical Trial on Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease (MND)

CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX: TRST), one of Canada's leading and most trusted licensed producers of cannabis, announced today that it has shipped its standardized CBD oil capsules to Australia's Gold Coast University Hospital. The capsules will be used in a study to determine the efficacy of…

Older Posts »

Search Again